Elizabeth A Prezio1, José A Pagán2, Kerem Shuval3, Dan Culica4. 1. Department of Epidemiology, University of Texas Health Science Center, Dallas. Electronic address: eaprezio@sbcglobal.net. 2. Center for Health Innovation, The New York Academy of Medicine, New York, New York; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Intramural Research Department, Economics and Health Policy Research Program, American Cancer Society, Atlanta, Georgia. 4. TMF Health Quality Institute, Austin, Texas.
Abstract
BACKGROUND: Limited evidence exists regarding the long-term effects of community health worker-led diabetes management programs on health outcomes and cost-effectiveness, particularly in low-income, ethnic minority populations. PURPOSE: To examine the long-term cost-effectiveness and improvements in diabetes-related complications of a diabetes education and management intervention led by community health workers among uninsured Mexican Americans. METHODS: Clinical data, changes in hemoglobin A1c over 12 months, and costs from an RCT of 180 uninsured Mexican Americans with type 2 diabetes conducted in 2006 were utilized for secondary analyses in 2012. Simulation modeling was used to estimate long-term cost and health outcomes using the validated Archimedes Model. The absolute differences for the incremental cost-effectiveness ratios and cumulative incidence of diabetes-related complications were derived by comparing intervention and control groups. RESULTS: During a 20-year time horizon, participants who received the intervention would be expected to have significantly lower hemoglobinA1c levels (p<0.001), fewer foot ulcers (p<0.001), and a reduced number of foot amputations (p=0.005) in comparison with a control group receiving usual medical care. An incremental cost-effectiveness ratio of $355 per quality-adjusted life year gained was estimated for intervention participants during the same time period. CONCLUSIONS: A simulated clinical trial suggests that a community health worker-led diabetes intervention is a cost-effective way to reduce diabetes-related complications for uninsured Mexican Americans during a 20-year horizon in comparison to usual medical care.
RCT Entities:
BACKGROUND: Limited evidence exists regarding the long-term effects of community health worker-led diabetes management programs on health outcomes and cost-effectiveness, particularly in low-income, ethnic minority populations. PURPOSE: To examine the long-term cost-effectiveness and improvements in diabetes-related complications of a diabetes education and management intervention led by community health workers among uninsured Mexican Americans. METHODS: Clinical data, changes in hemoglobin A1c over 12 months, and costs from an RCT of 180 uninsured Mexican Americans with type 2 diabetes conducted in 2006 were utilized for secondary analyses in 2012. Simulation modeling was used to estimate long-term cost and health outcomes using the validated Archimedes Model. The absolute differences for the incremental cost-effectiveness ratios and cumulative incidence of diabetes-related complications were derived by comparing intervention and control groups. RESULTS: During a 20-year time horizon, participants who received the intervention would be expected to have significantly lower hemoglobin A1c levels (p<0.001), fewer foot ulcers (p<0.001), and a reduced number of foot amputations (p=0.005) in comparison with a control group receiving usual medical care. An incremental cost-effectiveness ratio of $355 per quality-adjusted life year gained was estimated for intervention participants during the same time period. CONCLUSIONS: A simulated clinical trial suggests that a community health worker-led diabetes intervention is a cost-effective way to reduce diabetes-related complications for uninsured Mexican Americans during a 20-year horizon in comparison to usual medical care.
Authors: Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jeffrey A Reynolds; Ka Zang Xiong; Christopher D Jones; Betsy J Rodriguez; Krista K Proia; Nicolaas P Pronk; John M Clymer; Ron Z Goetzel Journal: Am J Prev Med Date: 2019-03 Impact factor: 5.043
Authors: Edwin B Fisher; Renée I Boothroyd; Emily A Elstad; Laura Hays; Amy Henes; Gary R Maslow; Clayton Velicer Journal: Clin Diabetes Endocrinol Date: 2017-05-25
Authors: Wen Ye; Shihchen Kuo; Edith C Kieffer; Gretchen Piatt; Brandy Sinco; Gloria Palmisano; Michael S Spencer; William H Herman Journal: Diabetes Care Date: 2021-05-06 Impact factor: 19.112
Authors: Teryl K Nuckols; Emmett Keeler; Laura J Anderson; Jonas Green; Sally C Morton; Brian J Doyle; Kanaka Shetty; Aziza Arifkhanova; Marika Booth; Roberta Shanman; Paul Shekelle Journal: Diabetes Care Date: 2018-05 Impact factor: 17.152
Authors: John G Lawrenson; Ella Graham-Rowe; Fabiana Lorencatto; Jennifer Burr; Catey Bunce; Jillian J Francis; Patricia Aluko; Stephen Rice; Luke Vale; Tunde Peto; Justin Presseau; Noah Ivers; Jeremy M Grimshaw Journal: Cochrane Database Syst Rev Date: 2018-01-15
Authors: Katherine B Roland; Erin L Milliken; Elizabeth A Rohan; Amy DeGroff; Susan White; Stephanie Melillo; William E Rorie; Carmita-Anita C Signes; Paul A Young Journal: Health Equity Date: 2017-05-01